Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth

Irving L. M. H. Aye,Fredrick J. Rosario,Theresa L. Powell,Thomas Jansson
DOI: https://doi.org/10.1073/pnas.1515484112
IF: 11.1
2015-09-28
Proceedings of the National Academy of Sciences
Abstract:Significance Obesity and metabolic syndrome may, in part, originate in fetal life. In particular, babies of mothers with obesity and/or gestational diabetes mellitus (GDM) are often large at birth and have increased adiposity, which predisposes them to the development of metabolic disease later in life. Maternal obesity and GDM are typically associated with low circulating levels of adiponectin (ADN), and we found that ADN supplementation to pregnant obese mice completely normalized the changes in placental function and prevented fetal overgrowth caused by maternal obesity. These findings suggest that strategies to increase ADN levels in maternal obesity and GDM may alleviate the adverse effects of these pregnancy complications on the fetus.
multidisciplinary sciences
What problem does this paper attempt to address?